Table 2. Tumor responses of the two groups based on mRECIST 1.1.
| Tumor response | TACE-HAIC group (n=32) | HAIC group (n=41) | P value |
|---|---|---|---|
| CR | 2 (6.3%) | 0 | |
| PR | 19 (59.4%) | 22 (53.7%) | |
| SD | 8 (25.0%) | 10 (24.4%) | |
| PD | 3 (9.4%) | 9 (22.0%) | |
| ORR (CR + PR) | 21 (65.6%) | 22 (53.7%) | 0.345 |
| DCR (CR + PR + SD) | 29 (90.6%) | 32 (78.0%) | 0.208 |
mRECIST, modified Response Evaluation Criteria in Solid Tumors; TACE, transarterial chemoembolization; HAIC, hepatic arterial infusion chemotherapy; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate.